Association between CNS-active drugs and risk of Alzheimer’s and age-related neurodegenerative diseases by Helena Cortes-Flores, Helena Cortes-Flores, Georgina Torrandell-Haro, Georgina Torrandell-Haro, Roberta Diaz Brinton, Roberta Diaz Brinton, Roberta Diaz Brinton

Get full text

Age and sex differences on anti-hyperglycemic medication exposure and risk of newly diagnosed multiple sclerosis in propensity score matched type 2 diabetics by Gregory L. Branigan, Georgina Torrandell-Haro, Francesca Vitali, Roberta Diaz Brinton, Kathleen Rodgers

Get full text

Association Between Specific Type 2 Diabetes Therapies and Risk of Alzheimer’s Disease and Related Dementias in Propensity-Score Matched Type 2 Diabetic Patients by Georgina Torrandell-Haro, Georgina Torrandell-Haro, Gregory L. Branigan, Gregory L. Branigan, Gregory L. Branigan, Roberta Diaz Brinton, Roberta Diaz Brinton, Roberta Diaz Brinton, Kathleen E. Rodgers, Kathleen E. Rodgers

Get full text

Statin therapy and risk of Alzheimer's and age‐related neurodegenerative diseases by Georgina Torrandell‐Haro, Gregory L. Branigan, Francesca Vitali, Nophar Geifman, Julie M. Zissimopoulos, Roberta Diaz Brinton

Get full text

Androgen‐targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer by Gregory L. Branigan, Georgina Torrandell‐Haro, Maira Soto, Edward P. Gelmann, Francesca Vitali, Kathleen E. Rodgers, Roberta Diaz Brinton

Get full text